1
|
Sharma S, Walia YK, Garg M, Verma SK. Tuning rheological performance of silica concentrated shear thickening fluid by using boric acid as additive. JOURNAL OF POLYMER ENGINEERING 2022. [DOI: 10.1515/polyeng-2022-0141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Shear thickening fluid (STF) are non-Newtonian fluids that usually behave as liquid in normal condition however under sudden impact, they transformed into a solid like structure with abrupt rise in viscosity. The rheological properties of these fluids play a significant role in energy dissipation. In the present work, effect of boric acid (BA) as an additive for the fine tuning of shear thickening (ST) behavior of colloidal silica-based shear thickening fluids (STFs) was investigated. STFs were synthesized with silica particles (600 nm) in liquid polyethylene glycol (PEG-200). Both the steady state and dynamic rheological studies of STFs were carried out to compare ST behavior of BA based STFs with only silica-based STFs. In steady state rheology, it was observed that max. viscosity increases four time compared to only silica based STF. In dynamic rheology, it was observed that the maximum G′ and G″ of the STF composition (69% + 1.2% BA) at a frequency of 70 rad/s has increased by ∼41 times and ∼14 times, respectively, when the deforming strain reaches at 100% strain. Both the steady state and dynamic rheological analyses have confirmed that boric acid based STFs exhibited higher shear/strain thickening behavior, as well as higher energy absorption property.
Collapse
Affiliation(s)
| | | | - Muskan Garg
- S.S Bhatnagar University Institute of Chemical Engineering and Technology , Panjab University , Chandigarh , India
| | - Sanjeev K. Verma
- Terminal Ballistics Research Laboratory , DRDO , Chandigarh 160030 , India
| |
Collapse
|
2
|
Żurowski R, Falkowski P, Zygmuntowicz J, Szafran M. Rheological and Technological Aspects in Designing the Properties of Shear Thickening Fluids. MATERIALS (BASEL, SWITZERLAND) 2021; 14:6585. [PMID: 34772127 PMCID: PMC8585178 DOI: 10.3390/ma14216585] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Revised: 10/28/2021] [Accepted: 10/29/2021] [Indexed: 11/21/2022]
Abstract
This work focuses on shear thickening fluids (STFs) as ceramic-polymer composites with outstanding protective properties. The investigation aims to determine the influence of raw material parameters on the functional properties of STFs. The following analyses were used to characterize both the raw materials and the STFs: scanning electron microscopy, dynamic light scattering, matrix-assisted laser desorption/ionization time-of-flight, chemical sorption analysis, rheological analysis, and kinetic energy dissipation tests. It was confirmed that the morphology of the solid particles plays a key role in designing the rheological and protective properties of STFs. In the case of irregular silica, shear thickening properties can be obtained from a solid content of 12.5 vol.%. For spherical silica, the limit for achieving shear thickening behavior is 40 vol.%. The viscosity curve analysis allowed for the introduction of a new parameter defining the functional properties of STFs: the technological critical shear rate. The ability of STFs to dissipate kinetic energy was determined using a unique device that allows pure fluids to be tested without prior encapsulation. Because of this, it was possible to observe even slight differences in the protective properties between different STFs, which has not been possible so far. During tests with an energy of 50 J, the dissipation factor was over 96%.
Collapse
Affiliation(s)
- Radosław Żurowski
- Faculty of Chemistry, Warsaw University of Technology, 3 Noakowskiego Str., 00-664 Warsaw, Poland; (P.F.); (M.S.)
| | - Paweł Falkowski
- Faculty of Chemistry, Warsaw University of Technology, 3 Noakowskiego Str., 00-664 Warsaw, Poland; (P.F.); (M.S.)
| | - Justyna Zygmuntowicz
- Faculty of Materials Science and Engineering, Warsaw University of Technology, 141 Wołoska Str., 02-507 Warsaw, Poland;
| | - Mikołaj Szafran
- Faculty of Chemistry, Warsaw University of Technology, 3 Noakowskiego Str., 00-664 Warsaw, Poland; (P.F.); (M.S.)
| |
Collapse
|
3
|
Smith WC, Bae J, Zhang Y, Qin B, Wang Y, Kozak D, Ashraf M, Xu X. Impact of particle flocculation on the dissolution and bioavailability of injectable suspensions. Int J Pharm 2021; 604:120767. [PMID: 34087414 DOI: 10.1016/j.ijpharm.2021.120767] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Revised: 05/27/2021] [Accepted: 05/30/2021] [Indexed: 11/13/2022]
Abstract
Injectable suspensions occasionally exhibit variations in dissolution and bioavailability, which may impact the clinical outcome of the drug product. Here, variation in the injection method (i.e., applied shear) for triamcinolone acetonide (TA) injectable suspension (40 mg/mL) altered the flocculation state of the particles and subsequently their dissolution. Notably, TA suspensions contained primary particles of approximately 2 µm and secondary flocculates of tens of microns. The conversion between flocculated and deflocculated particles was rapid, reversible and highly shear dependent. As such, changing shear rates during laser diffraction (LD) measurement like stirring rate, sonication, and sample introduction method (micropipette vs 25-gauge needle) may result in variability in particle size distributions (PSD) that have the potential to alter drug dissolution. Furthermore, a non-sink, discriminatory in vitro release testing (IVRT) method was developed, which combined in-situ fiber optic UV with LD to simultaneously monitor the dissolution and changing PSD of the suspension. The simultaneously measured dissolution and PSD data showed that flocculated and deflocculated particles followed different dissolution pathways. Importantly, deflocculated particles dissolved up to six times faster than the flocculated particles. Similar shear-induced changes during injection could occur in a clinical setting and have implications for drug bioavailability.
Collapse
Affiliation(s)
- William C Smith
- Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Jungeun Bae
- Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Ying Zhang
- Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Bin Qin
- Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Yan Wang
- Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Darby Kozak
- Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Muhammad Ashraf
- Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
| | - Xiaoming Xu
- Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
| |
Collapse
|